FMP
NFL Biosciences SA
ALNFL.PA
EURONEXT
NFL Biosciences SA, a biotechnology company, develops natural addiction withdrawal solutions for smokers. Its natural drug candidate in pipeline to cure tobacco addiction include NFL-101, a tobacco extract that is in Phase III clinical trial targeting smoking addiction; NFL-201, a cannabis and tobacco extract, which is in preclinical stage; and NFL-301, a botanical extract (traditional Chinese medicine) that is in preclinical stage. The company was incorporated in 2006 and is based in Castelnau-le-Lez, France.
2.05 EUR
0.015 (0.733%)
About
ceo
Dr. Ignacio Faus M.B.A., Ph.D.
sector
Healthcare
industry
Biotechnology
website
https://www.nflbiosciences.com
exchange
EURONEXT
Description
NFL Biosciences SA, a biotechnology company, develops natural addiction withdrawal solutions for smokers. Its natural drug candidate in pipeline to cure tobacco addiction include NFL-101, a tobacco extract that is in Phase III clinical trial targeting smoking addiction; NFL-201, a cannabis and tobacco extract, which is in preclinical stage; and NFL-301, a botanical extract (traditional Chinese medicine) that is in preclinical stage. The company was incorporated in 2006 and is based in Castelnau-le-Lez, France.
CIK
N/A
ISIN
FR0014003XT0
CUSIP
N/A
Address
199 Rue Helene Boucher
Phone
33 4 11 93 76 67
Country
FR
Employee
4
IPO Date
Jul 5, 2021
Summary
CIK
-
Exchange
EURONEXT
Industry
Biotechnology
Sector
Healthcare
CUSIP
-
ISIN
FR0014003XT0
Country
FR
Price
2.04
Beta
1.77
Volume Avg.
71.02k
Market Cap
19.66M
Shares
-
52-Week
0.94-3.32
DCF
0.28
ROE
-
ROA
-
Operating Margin
-
Debt/Equity
-
P/E
-3.72
P/B
-
Website
https://www.nflbiosciences.com
Historical Prices
We are unable to load the chart at this time.
Financial Statement
We are unable to load the chart at this time.
Earnings
We are unable to load the chart at this time.
Upgrades and Downgrades
We are unable to load this data!
People Also Watch
Financial Information
Financial Summary Real-Time Price
Financial Statements
Financial Quarter Statements
Ratios Analysis
Dupont Analysis
Free Cashflow
Operating Data
Balance Sheet Data
Financial Modelling
Discounted Cashflow Model
Discounted Cashflow Model Levered
Free Cashflow Build-Up
Terminal Value
Intrinsic Value
Weighted Average Cost of Capital
Market Information
Stock Value
Latest ALNFL.PA News
It looks like there's no news available.
